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Abstract
Background:  Cationic lipid DNA complexes based on DOTAP (1,2-dioleoyl-3-
(trimethyammonium) propane) and mixtures of DOTAP and cholesterol (DC) have been
previously optimized for transfection efficiency in the absence of serum and used as a non-viral gene
delivery system. To determine whether DOTAP and DC lipid DNA complexes could be obtained
with increased transfection effciency in the presence of high serum concentrations, the
composition of the complexes was varied systematically and a total of 162 different complexes
were analyzed for transfection efficiency in the presence and absence of high serum concentrations.
Results: Increasing the ratio of DOTAP or DC to DNA led to a dose dependent enhancement of
transfection efficiency in the presence of high serum concentrations up to a ratio of approximately
128 nmol lipid/µg DNA. Transfection efficiency could be further increased for all ratios of DOTAP
and DC to DNA by addition of the DNA condensing agent protamine sulfate (PS). For DOTAP
DNA complexes with ratios of ≤  32 nmol/µg DNA, peak transfection efficiencies were obtained
with 4 µg PS/µg DNA. In contrast, increasing the amount of PS of DC complexes above 0.5 µg PS
/µg DNA did not lead to significant further increases in transfection efficiency in the presence of
high serum concentrations. Four complexes, which had a similar high transfection efficiency in cell
culture in the presence of low serum concentrations but which differed largely in the lipid to DNA
ratio and the amount of PS were selected for further analysis. Intravenous injection of the selected
complexes led to 22-fold differences in transduction efficiency, which correlated with transfection
efficiency in the presence of high serum concentrations. The complex with the highest transfection
efficiency in vivo consisted of 64 nmol DC/ 16 µg PS/ µg DNA. Physical analysis revealed a predicted
size of 440 nm and the highest zeta potential of the complexes analyzed.
Conclusions: Optimization of cationic lipid DNA complexes for transfection efficiency in the
presence of high concentrations of serum led to the identification of a DC complex with high
transduction efficiency in mice. This complex differs from previously described ones by higher lipid
to DNA and PS to DNA ratios. The stability of this complex in the presence of high concentrations
of serum and its high transduction efficiency in mice suggests that it is a promising candidate vehicle
for in vivo gene delivery.
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Background
Cationic lipid DNA complexes have been used as a non-
viral gene delivery system in cell culture [1–5] and in sev-
eral animal models [6–11]. Apart from their relative ease
of production and simple complexing protocols, risks at-
tributed to viral vectors has prompted further interest in
cationic lipid DNA gene delivery systems.
Only a few cationic lipid DNA complexes have been
shown to work in the presence of biological fluids such as
serum [12–14] and most in vitro transfection protocols
routinely require that the target cells are exposed to the
cationic lipid DNA complex in the absence of serum
[3,15,16]. Human gene therapy phase 1 trials with cation-
ic lipid DNA complexes for treatment of cancer and cystic
fibrosis only led to low and transient expression of the
therapeutic gene [10]. Thus, there is an intense effort to
optimized cationic lipid DNA complexes in order to in-
crease their gene transfer activity in the presence of physi-
ological fluids such as serum. Current efforts in improving
cationic lipid DNA complexes are mainly based upon a
better understanding of the barriers for transfection [17–
19] and the relationship between structure and function
[20–27]. Amongst the barriers for transfection, serum has
been reported to exhibit its inhibitory effect either by di-
minishing the amount of lipid DNA complexes associat-
ing with the target cells [3] or via serum proteins binding
to lipid DNA complexes thereby diminishing their ability
to deliver the transgene [28]. Lipoproteins have recently
been incriminated as the major component responsible
for the inhibitory effect of serum [29].
DOTAP (1,2-dioleoyl-3-(trimethyammonium) propane)
and an equimolar mixture of DOTAP and cholesterol
(DC) were selected as lipids in this study, since they are
readily available and have already been extensively char-
acterized. Initially, DOTAP was shown to give good in vivo
transduction efficiency at a ratio of 35 nmol/µg DNA [30].
Addition of the helper lipid cholesterol enhanced in vivo
transduction efficiency [31,32]. In another study, pro-
tamine sulfate was also shown to enhance transduction ef-
ficiency of DC-chol (3beta-[N',N'-dimethylaminoethane]
- carbamoyl-cholesterol) / DOPE (dioleoylphosphatidyl-
ethanolamine) and DOTAP / DOPE complexes [33]. In
these studies, complexes were first optimized for transfec-
tion efficiency in the cell culture in the presence of low
concentrations of serum. A few selected complexes were
subsequently analyzed for transduction efficiency in vivo.
Since the requirements for good transfection efficiency in
cell culture might differ from the ones in vivo, the most ef-
ficient complexes in vivo might have been missed. Serum,
which has been shown to inhibit transfection efficiency of
cationic lipid DNA complexes [3,12,28], seems to be an
important barrier to in vivo transduction efficiency. There-
fore, complexes spanning a wide range of ratios of lipid to
DNA to protamine sulfate were systematically analyzed in
the present study for transfection efficiency in the pres-
ence of high concentrations of serum. To determine the
relevance of these cell culture experiments for in vivo gene
transfer, transduction efficiencies of selected complexes
were also determined after intravenous injection of lipid
DNA complexes in mice. The complex with the highest
transfection efficiency in the presence of high serum con-
centrations in cell culture also gave the highest transduc-
tion efficiency after intravenous injection into mice. The
optimizedd complex differed from the previously identi-
fied ones by higher lipid to DNA and protamine sulfate to
DNA ratios. Since inhibition of transfection in cell culture
by high serum concentrations correlated well with in vivo
transduction efficiency, the effect of serum on biophysical
properties of the complexes was also analyzed.
Results
Transfection efficiency of lipid DNA complexes in vitro
The lipids DOTAP and DOTAP-cholesterol (DC) were
chosen for the preparation of cationic lipid DNA com-
plexes since they gave good transfection efficiency in cell
culture and in animal models [12,30,34–36]. To deter-
mine the optimal ratio of lipid to DNA, one µg of a plas-
mid encoding the luciferase reporter gene was complexed
with increasing amounts of DOTAP (Fig. 1A) or DC (Fig.
1B). The functionality of the complexes were analyzed by
transfection of 293A target cells and subsequent measure-
ment of the luciferase activity in the cell extracts of the
transfected cells. For both lipids a dose dependent in-
crease in transfection efficiency was observed. Since pro-
tamine sulphate was reported to enhance transfection
efficiency of cationic lipid DNA complexes [33], it was
added in increasing concentrations to 1 µg of plasmid
DNA prior to the addition of the lipids at all the previous-
ly analyzed lipid to DNA ratios. Protamine sulphate en-
hanced transfection efficiency by a factor of 10 to 100 at
all lipid to DNA ratios tested. The strongest increase was
observed at low lipid to DNA ratios. For DOTAP, the high-
est luciferase activities were obtained with 4 to 8 µg pro-
tamine sulphate at high DOTAP to DNA ratios (Fig. 1A).
For high DC to DNA ratios, the transfection efficiency did
not vary considerably in the presence of 0.5 to 16 µg pro-
tamine sulphate indicating that a wide range of protamine
sulphate concentration could be used for complex forma-
tion. Similar experiments with a plasmid encoding the
GFP reporter gene revealed that at the optimal ratios of li-
pid to DNA to protamine sulfate about 30–40% of the
cells were transfected in the presence of 10% fetal bovine
serum and up to 70% of the cells were transfected when
transfection was done in the absence of serum (data not
shown). Similar high transfection efficiencies were ob-
tained with selected complexes in other immortalized cell
lines (data not shown).BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/12
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Toxicity of lipid DNA transfection complexes
Since toxicity of the lipid DNA complexes could limit
their use, cell viability was analyzed after transfection with
various ratios of lipid to DNA to protamine sulphate. For
ratios of up to 64 nmol DOTAP/µg DNA cell viability was
higher than 80% of the viability of untransfected cells in-
dependent of the amount of protamine sulfate added (Fig.
2A). At higher DOTAP to DNA ratios (> 64 nmol DOTAP/
µg DNA), toxicity peaked at 8 µg protamine sulfate/µg
DNA. High cell viabilities were observed for complexes
containing DC at ratios ≤  64 nmol lipid/µg DNA with lim-
ited correlation of the amount of protamine sulfate added
to the complexes.
Transfection efficiency of lipid DNA complexes at high se-
rum concentrations
Serum has been previously reported to interfere with
transfection efficiency of lipid DNA complexes
[12,28,36]. In these studies, lipid DNA complexes were
usually optimized for transfection efficiency in the ab-
sence of serum, and small number of complexes were sub-
sequently analyzed for transfection efficiency in the
presence of high serum concentrations. To determine,
whether DOTAP and DC lipid DNA complexes could be
obtained with increased transfection efficiency in the
presence of high serum concentrations, the 162 different
complexes analyzed above were also studied for transfec-
tion efficiency after incubation with 66% serum. Lipid
DNA complexes composed of ≤  16 nmol lipid/µg DNA
and ≤  2 µg protamine sulfate/µg DNA were strongly inhib-
ited by high serum concentrations (compare Fig. 1A and
3A), while complexes with higher amounts of DOTAP
were inhibited to lesser extent or not at all. Peak transfec-
tion efficiencies of DOTAP complexes with less 16 nmol
lipid/µg DNA in the presence of high concentrations of se-
rum were obtained with 4 µg protamine sulfate/ µg DNA
(Fig. 3A). At higher DOTAP concentrations protamine sul-
fate affected transfection efficiency in the presence of high
serum concentrations to a lesser extent. Transfection effi-
ciencies of DC DNA complexes were only inhibited by
high serum concentrations at high ratios of protamine sul-
fate to DNA (Fig. 1B versus 3B). Surprisingly, high serum
concentrations increased transfection efficiency of DC
complexes in the absence of protamine sulfate. Transfec-
tion efficiencies of complexes containing ≤  4 nmol DC/µg
DNA were also increased by high serum concentrations at
low amounts of protamine sulfate (0.5 to 4 µg protamine
sulfate/µg DNA). However, the highest transfection levels
in the presence of high serum concentrations were ob-
tained with DC complexes composed of 64 nmol lipid/µg
DNA in the presence of a wide range of protamine sulfate
to DNA ratios (0.5 to 64µg protamine sulfate/µg DNA).
On the basis of these findings, two ratios of lipid to DNA
to protamine sulphate, which seem to cover the range of
efficient lipid DNA complexes, were chosen for each lipid
from the 162 different complexes analyzed for further
characterization of the effect of serum on transfection ef-
ficiency. Complexes with low lipid to DNA ratios consist-
ed of 16 nmol DOTAP (DOTAP-low) or DC (DC-low)/1
µg DNA with 1 µg protamine sulphate, while complexes
with a high lipid to DNA ratio were formed with 64 nmol
DOTAP (DOTAP-high) or DC (DC-high)/1 µg DNA with
16 µg of protamine sulphate. The in vitro transfection effi-
ciencies at low serum concentrations were very similar for
DOTAP-low, DOTAP-high, DC-low, and DC-high, rang-
ing from approximately 1 to 2 ×  107 RLU/µg protein ex-
tract (Fig. 4) and did not change notably during
preincubation of the complexes for up to four hours prior
Figure 1
Transfection efficiency of DOTAP (A) or DC (B) DNA com-
plexes formed at different ratios of lipid to protamine sulfate
to DNA. One µg luciferase expression plasmid was mixed
with the indicated amount of protamine sulfate prior to addi-
tion of the lipids. Complexes were added to 293A cells in the
presence of 10% serum for 48 hours when the luciferase
activity of the cell extracts was determined. RLU: relative
light units. The mean and the standard deviation (error bars)
of triplicates is shown.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/12
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to their addition to the cells (data not shown). However,
mixing of the four selected complexes with 2 volumes of
serum for less than 10 minutes, for 1 hour, or for 2 hours
prior to transfection and subsequent determination of lu-
ciferase activities revealed striking differences. The DC-
high complex was only marginally affected by 2 volumes
of serum (Fig. 4). Preincubation with serum for two hours
inhibited transfection with DC-low and DOTAP-high
complexes by approximately 10- and 20-fold, respective-
ly. Transfection with DOTAP-low complexes was almost
completely blocked by preincubation with serum (Fig. 4).
In vivo transfection efficiency of lipid DNA complexes
To determine, the transfection efficiency of the four select-
ed complexes in vivo, 25 µg luciferase expression plasmid
were mixed with the lipids and protamine sulfate at the
indicated ratios and injected into the tail vein of mice.
Twenty four hours later the luciferase activity was deter-
mined in the lung extracts, the organ with the highest re-
porter gene activity following intravenous injection of
cationic lipid DNA complexes ([34,37]; data not shown).
The highest luciferase activities were obtained with the
DC-high complex (Fig. 5), which was also least inhibited
by high serum concentrations (Fig. 4). Intermediate levels
of transfection efficiencies were obtained with DC-low
and DOTAP-high, both of which also showed intermedi-
ate levels of inhibition by high serum concentrations.
DOTAP-low transfection complexes, which were strongly
inhibited at high serum concentrations, only gave low lu-
ciferase activities in vivo. Thus, the in vivo transfection effi-
ciency seems to correlate well with the transfection
efficiency in cell culture in the presence of high serum
concentrations.
Physical properties of lipid-DNA transfection complexes
The size and the charge of the four selected lipid DNA
complexes was examined by light scattering and laser elec-
trophoresis to determine the importance of these param-
eters for in vivo transfection efficiency and serum
inhibition. The four selected complexes were positively
charged with charges ranging from 13.1 mV for DOTAP-
low to 19.6 mV for DC-high (Table 1). With the exception
of DC-low complexes, lower zeta potentials were ob-
served when the complexes were formed in the absence of
protamine sulfate (data no shown). The largest size with
0.44 µm was predicted for DC-high complexes (Table 1),
while the other three complexes had a predicted size of
0.12 to 0.19 µm. For these three complexes, protamine
sulfate reduced the size of complexes since control com-
plexes formed at the same lipid to DNA ratios in the ab-
sence of protamine sulfate had sizes ranging from 0.42
µm to 0.45 µm (data not shown), confirming the previ-
ously reported condensing effect of protamine sulfate
[31,33]. However, DC-high complexes were not con-
densed by addition of protamine sulfate, suggesting that a
small size of the complexes is not required for good trans-
fection efficiency in vivo and in the presence of high serum
concentrations.
Turbidity of lipid-DNA complexes following exposure to 
fetal bovine serum
The sensitivity of the complexes to serum seems to be an
important parameter for in vivo transfection efficiency. To
directly assess the effect of serum on the structure of the li-
Figure 2
Cytotoxicity of DOTAP (A) or DC (B) DNA complexes
formed at different ratios of lipid to protamine sulfate to
DNA. Two days after transfection in the presence of 10%
serum the toxicity of the complexes was determined by the
MTT assay. Values are expressed as the percent viability of
untransfected cells.
Table 1: Physical properties of the lipid DNA complexes
Complex Size (µm) Zeta potential (mV)
DOTAP-low 0.19 ± 0.084 13.1 ± 5.6
DOTAP-high 0.14 ± 0.038 16.7 ± 1.8
DC-low 0.12 ± 0.024 15.9 ± 2.1
DC-high 0.44 ± 0.088 19.6 ± 3.9
The mean size and the standard deviation of the major population of 
the different lipid DNA complexes are indicated.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/12
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pid-DNA complexes, the turbidity of the complexes was
determined before and after addition of two volumes of
serum. After addition of serum the turbidity increased
within 10 minutes but remained rather constant for the
rest of the observation period in case of DOTAP-low, DC-
low and DC-high complexes (Figure. 6). This might indi-
cate formation of rather stable complexes with little tend-
ancy to additional aggregation. For DOTAP-high
complexes we observed a continous increase in turbidity
after addition of serum for at least 150 minutes, indicating
aggregation of the complexes. Since the transfection effi-
ciency of DOTAP-low complexes was inhibited to a larger
extent by high serum concentrations than the transfection
efficiency of DOTAP-high complexes (Fig. 4), stable tur-
bidity values after addition of serum were not predictive
for resistance to inhibition of transfection efficiency by
high serum concentrations.
Effect of serum on interaction of the lipids
A second approach, based on fluorescence energy transfer
(FRET) was used to study lipid interactions during com-
plex formation and to assess the direct effect of serum on
the interaction between the lipids. During preparation of
the liposomes, the fluorescent molecules N-NBD-PE (do-
nor) and RH-PE (acceptor) are incorporated at a low mo-
lar ratio (1% mol/mol of both NBD-PE and RH-PE) in the
vesicle bilayer. Under steady state conditions with appro-
priate ratios of NBD-PE to RH-PE, the fluorescence emit-
ted by NBD-PE is reduced by RH-PE because the emission
wavelength of NBD-PE overlaps with the excitation wave-
length of RH-PE. When a perturbation of the lipid bilayer
occurs as a result of interaction with either DNA or serum
components a decrease in the surface densities of RH-PE
and NBD-PE occurs resulting in an increase in NBD-PE
fluorescence which was measured in this experiment. An
increase in NBD-PE emission intensity therefore indicates
a reduction in FRET probably due to changes in the con-
formation of the liposomes or complexes.
For DC-low, addition of DNA and protamine sulphate to
the labelled liposomes led to a >10% increase in the emis-
Figure 3
Transfection efficiency at high serum concentrations of
DOTAP (A) or DC (B) DNA complexes formed at different
ratios of lipid to protamine sulfate to DNA. One &#956;g
luciferase expression plasmid was mixed with the indicated
amount of protamine sulfate prior to addition of the lipid.
Complexes were incubated with two volumes of serum for
one hour and added to 293A cells. One day later the luci-
ferase activity of the cell extracts was determined. RLU: rela-
tive light units. The mean and the standard deviation (error
bars) of triplicates is shown.
Figure 4
Inhibition of the transfection efficiency at high concentration
of serum. Selected complexes (DOTAP-high, DOTAP-low,
DC-high, DC-low) were incubated without serum for two
hours (normal) or with two volumes of serum for the indi-
cated time prior to transfection of 293A cells and subsequent
determination of luciferase activity in the cell extracts. The
mean of triplicates and the standard deviation are given as
relative light units (RLU) per µg cell extract.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/12
Page 6 of 10
(page number not for citation purposes)
sion intensity of NBD-PE, while the increase was less strik-
ing during formation of DC-high, DOTAP-low, and
DOTAP-high complexes (Fig. 7). Fluorescence intensity
increased after addition of serum for all complexes (>
40%) with minor differences between different protocols
(Fig. 7). To disrupt the complexes completely, Triton X-
100 was added, which led to a further increase in fluores-
cence intensities. The highest levels of fluorescence inten-
sity obtained after addition of Triton X-100 was very
similar for all the complexes (data not shown).
Discussion and Conclusions
Screening of a large number of DOTAP or DOTAP choles-
terol DNA complexes spanning a wide range of ratios of li-
pid to DNA in the presence or varying amounts of
protamine sulfate for transfection efficiency in the pres-
ence of high serum concentrations led to the identifica-
tion of complexes highly resistent to the inhibitory effects
of serum. The transfection efficiency of complexes con-
taining low amounts of DC and protamine sulfate could
even be increased by addition of high serum concentra-
tions. This might be due to an enhanced binding of DC
based complexes to the target cells with increasing serum
concentrations [12] in the absence of destabilizing effects
of serum on these complexes. Why a similar effect is not
noticed with complexes containing high amounts of DC
may be due to saturation resulting from a larger amount
of DC associating with the cells. Alternatively, serum com-
ponents might associate with complexes containing low
amounts of DC more efficiently. However, the highest
transfection efficiencies in the presence of high serum
concentrations were obtained with complexes containing
high amounts of DC (≥  64 nmol lipid/µg DNA) in the
presence of a wide range of protamine sulfate to DNA ra-
tios (0.5 to 64 µg protamine sulfate/µg DNA). Interesting-
ly, the transfection efficiency of four selected complexes
(DOTAP-low, DOTAP-high, DC-low, DC-high) in the
presence of high serum concentrations, but not at low se-
rum concentrations, paralleled transduction efficiency in
vivo after intravenous administration. This suggests that
serum is a main barrier to in vivo gene transfer after intra-
venous injection of cationic lipid DNA complexes. How-
ever, it is important to note, that other routes of
administration might differ in the requirements for good
transduction efficiency [32,37].
The highest transduction efficiencies after intravenous in-
jection were obtained with DC-high complexes composed
of 64 nmol DC/µg DNA/16 µg protamine sulfate. This
complex differs from previously used ones, which were
similar in composition to our DC-low complexes, by a
higher ratio of DC to DNA. Whether the higher ratio of
protamine sulfate to DNA also contributes to higher trans-
duction efficiency in vivo in comparison to DC-low like
complexes remains to be determined, but similar transfec-
tion efficiencies of complexes containing 64 nmol DC/µg
Figure 5
Transduction efficiency of the selected complexes in mice. 25
µg of DNA was complexed at the ratios of lipid to DNA to
protamine sulfate described in the text in a final volume of
300 µl PBS. Threehundred µl of the complexes were injected
into the tail vein of 6–8 weeks old Balb C mice. After 24
hours luciferase expression in the lungs was determined and
normalised per µg protein extract. Values represent the
mean and the standard deviation of five mice per group.
Figure 6
Changes in turbidity of lipid DNA complexes following addi-
t i o n  o f  h i g h  c o n c e n t r a t i o n s  o f  s e r u m .  T h e  s e l e c t e d  c o m -
plexes were prepared at the ratios described in the text in a
final volume of 200 µl. The volume was adjusted to 600 µl
and the absorbance at 600 nm was determined prior to and
after addtion of 400 µl of serum. The absorbance of 40%
serum in the absence of lipid and DNA was subtracted as
background. The experiment was repeated thrice with simi-
lar findings.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/12
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DNA and varying amounts of protamine sulphate (rang-
ing from 0.5 to 32 µg/µg DNA) in the presence of high
concentrations of serum argue against it.
Our attempt to correlate physical properties of the com-
plexes with high transfection efficiency in the presence of
high serum concentrations was not successful. Neither
size, charge, lipid interactions or lack of aggregation par-
alleled transfection efficiency in the presence of high se-
rum concentrations. One of the reasons for this failure
might be the fact that the structure of the complexes can
only be determined for the dominating population of
complexes. Since presumably only the DNA of a small
percentage of complexes reaches the nucleus for transcrip-
tion a minor population of complexes undetectable by bi-
ophysical methods might actually be the biologically
active one leading to transfection. In this case, only phys-
ical separation of the complexes will allow the establish-
ment of a firm correlation of physical parameters with
transfection efficiency. At present, comparison of a large
number of different complexes and selection of the most
efficient ones for further analysis is still required. Transfec-
tion efficiency in the presence of high serum concentra-
tions might be a good initial screening system prior to in
vivo experiments.
By systematically varying the ratio of lipid to DNA to pro-
tamine sulfate we identified a lipid DNA complex (DC-
high) composed of 64 nmol DC/µg DNA/16 µg pro-
tamine sulfate with a predicted size of 440 nm and zeta
potential of 19.6 mV that is hardly inhibited by high se-
rum concentrations and that gave the highest in vivo trans-
duction efficiency after intravenous injection into mice.
This DC-high complexe differs from previously described
DC complexes [38] by increased ratios of lipid and pro-
tamine sulfate to DNA. These parameters might contrib-
ute to the good transduction efficiency of DC-high
complexes in vivo. Further characterization of the biologi-
cal properties of this complex is required to determine its
usefulness for gene therapy approaches.
Materials and Methods
Chemicals
1,2-Dioleoyl-3-trimethylammonium-propane (DOTAP),
cholesterol, NBD-PE (N-[7-nitrobenz-oxa-1,3-diazoyl-4-
yl]-phosphatidylethanolamine) and Rh-PE (N-[lissa-
mine-rhodamine-B-sulfonyl]-phosphatidyleth-
anolamine) were purchased from Avanti Polar Lipid
(Alabaster, AL, USA). Protamine sulphate and MTT
(Dimethyl-thiazol-diphenyl-tetrazolium-bromide) were
from Sigma (Darmstadt, Germany). The Luciferase assay
kit was purchased from Promega (Manheim, Germany).
All other chemicals were of reagent grade.
Plasmids
The reporter plasmid containing the firefly luciferase
cDNA protein was cloned into the backbone of pcDNA3.1
plasmid (Invitrogen, Groningen, Netherlands). The ex-
pression of the reporter gene is under the control of Cy-
tomegalovirus (CMV) immediate early promoter. The
plasmid pEGFP-C1 expressing the enhanced green fluo-
rescent protein cDNA driven by the CMV promoter was
obtained from Clonetech (Heidelberg, Germany). Plas-
mid DNA was prepared with the Qiagen plasmid Giga kit
(Valentia, CA, USA) according to the manufacturer's in-
struction and dissolved in phospate buffered saline (PBS,
pH 7.4).
Preparation of liposomes
Cationic liposomes containing DOTAP or DOTAP and
cholesterol in a 1:1 molar ratio were prepared using a pre-
viously described method [39]. The lipid was initially
dried from chloroform, subsequently dispersed in PBS
(pH 7,4) and shaken at a temperature above the gel-to-liq-
uid-crystalline transition temperature of the lipid (50°C)
for 10 min. The milky solution was sonicated for 10 min
under temperature control using a Branson sonifier 250
(Branson Sci., USA) at minimum ultrasound power to
avoid extensive bubble formation.
Figure 7
Lipid-lipid interactions during complex formation and after
addition of serum. The relative fluorescence intensities of
DOTAP and DC liposomes containing both NBD-PE and Rh-
PE were determined at 520 nm for five minutes. DOTAP-
high, DOTAP-low, DC-high and DC-low complexes were
formed by addition of DNA and protamine sulphate at the
ratios described in the text while continously monitoring the
fluorescence intensities. The change in the fluorescence
intensities was determined after addition of serum and Tri-
ton-X 100. Values were corrected for the dilution factor
experimentally determined and are expressed as percentage
of the mean fluorescence intensity after addition of Triton-X
100. The experiment was repeated thrice with similar
results.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/12
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Preparation of lipid DNA complexes
The plasmid DNA was diluted to a concentration of 1 µg/
µl in PBS (pH 7.4) prior to complex formulation. All rea-
gents were sterile and were adjusted to room temperature
before complex preparation. Protamine sulphate was add-
ed to DNA diluted in PBS at a weight ratio of 1 µg pro-
tamine sulphate per µg DNA (DC- and DOTAP-low) or 16
µg protamine sulphate per 1 µg DNA (DC- and DOTAP-
high), the mixture was vortexed briefly and incubated at
room temperature for 5 minutes. The respective amounts
of DOTAP (DOTAP-high: 64 nmol/µg DNA; DOTAP-low:
16 nmol/µg DNA) or DC (DC-high: 64 nmol/µg DNA;
DC-low: 16 nmol/µg DNA) were added to the solution at
a final volume of 50 µl, the mixture was vortexed briefly
and further incubated for ten minutes at room tempera-
ture. Stable fluorescence intensity values were obtained
within minutes after addition of compounds (Fig. 7) indi-
cating rapid completion of mixing.
Laser electrophoresis and light scattering
The electrophoretic mobilities of the complexes were
measured using a Zetasizer 4 device (Malvern, U.K.). Lipid
DNA complexes were formed with 4 µg DNA and the re-
spective amounts of Lipid and protamine sulfate in a vol-
ume of 200 µl. The volume was adjusted to 4 ml by
addition of PBS. The mobilities of the particles were meas-
ured using a modulation frequency of 1000 Hz, the elec-
trode current was 5 mA. Light scattering at 90° was
measured using the same sample. Multimodal analysis
was used for the deconvolution of the data. The number
distribution mode were used for the data analysis.
Transfection of mammalian cells in vitro
About 40000 293A cells (Quantum Biotechnology Inc.,
Montreal, Canada) were seeded into a 24 well plate and
grown in a 37°C incubator in a 5% CO2 in a final volume
of 1 ml DMEM from GIBCO (Karlsruhe, Germany). The
next day, the cells (60–70% confluent) were then trans-
fected by adding 50 µl complex solution containing 1 µg
of DNA to each well of the plate without removing the
10% fetal bovine serum containing medium from the
cells. The cells were then incubated for 48 hours without
removing the medium. When transfections were set up in
the absence of serum, cells were incubated with the com-
plexes for 4 hours in serum free medium before the medi-
um was replaced with fresh medium containing 10% fetal
bovine serum. To study serum inhibition, complexes
formed as described above were incubated with two vol-
umes of heat inactivated fetal calf serum (GIBCO;
Karsruhe, Germany) prior to addition to 293A cells. Two
days after transfection cells were washed with PBS and
lysed with 200 µl lysis buffer (0.05% Triton X-100, 2 mM
EDTA, 0.1 M Tris, pH 7.8) through one freeze-thaw cycle.
The cell lysate was then transferred to microcentrifuge
tubes and centrifuged for 10 minutes at 14000 g at 4°C.
The supernatant was diluted one to twenty and 20 µl of
the diluted sample was used for the luciferase assay ac-
cording to the manufacturer's instructions. The lumines-
cence was determined in a luminometer from Murex
(Germany) The protein concentration was determined us-
ing a multiplate assay from Biorad (Hilden, Germany) ac-
cording to the manufacturer's instructions. For
quantification, a standard containing known amounts of
BSA in luciferase lysis buffer was included. Reporter gene
expression was expressed as relative light units (RLU) per
µg protein extract. Each data point represents the mean ±
the standard deviation of triplicate experiments.
Cytotoxicity assay
293A cells transfected as described above were assayed for
cell survival using the MTT reagent. The MTT reagent was
diluted in PBS to a final concentration of 2.5 mg/ml then
filtered using a 0.22 µm filter. 50 µl of the stock solution
was then added to each well of the tranfected plates and
incubated for 1 hour at 37°C under 5% CO2. After an
hour the medium was removed and 200 µl of 0.04 N HCl
was used to dissolve the resulting blue formazan crystals
in living cells. The extract was then diluted 1:4 in 0.04 N
HCl and the optical density was determined at 540 nm.
Untransfected 293A cells were used as control.
In vivo transfection
The animal experiments were approved by the local au-
thorities. Female Balb-C mice 6–8 weeks old were ob-
tained from the experimental animal services of the
University of Leipzig and housed in accordance with insti-
tutional guidelines. Individual mice in groups of five were
injected via the lateral tail vein with 25 µg of DNA formu-
lated in the complexes in a total volume of 300 µl. Twen-
ty-four hours following i.v. injection, the mice were killed
by cervical dislocation and the lungs were collected. The
organ was then washed with PBS and homogenized in
500 µl of lysis buffer (Promega, Mannheim, Germany).
After two cycles of freeze-thaw, the homogenates were
centrifuged at 14000 g at 4°C for 10 minutes. The super-
natant was analyzed for luciferase activity as described
above.
Turbidity assay
The relative absorbance of the complexes was determined
at 600 nm according to a method described [38]. Com-
plexes were formed with 4 µg DNA and the respective
amounts of lipids and protamine sulfate in a volume of
200 µl. After addition of 400 µl PBS the absorbance of the
complexes was determined for 10 minutes in the absence
of serum with PBS as the blank control. A volume of 400
µl serum was added and the kinetics of the turbidity was
measured with stirring at 37°C for 5 hours. Serum in PBS
was used as the blank control.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/12
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Multi-step lipid mixing assay
The multi-step lipid mixing assay was adapted from the
methods described by Wasan [21]. Structural reorganiza-
tion of the complexes after binding of DNA and serum
was followed by the fluorescence resonance energy trans-
fer method, using NBD-PE and Rh-PE. The liposomes
were composed of DOTAP or DC and 1% (mol/mol) of
both NBD-PE and Rh-PE. The liposomes with the incor-
porated fluorophores were suspended in 2 ml of PBS (pH
7.4). The fluorescence measurements were carried out at
25°C with an excitation wave length of 465 nm. The emis-
sion was recored at a wavelength of 520 nm using a Per-
kin-Elmer LS50B spectrofluorometer. The recording
started after the system had almost reached equilibrium.
Initially, fluorescence readings of the respective liposomes
(DOTAP-low and DC-low: 64 nmol; DOTAP-high and
DC-high: 256 nmol) in 2 ml PBS were taken continuously
at 25°C for 5 minutes, 4 µg DNA mixed with protamine
sulfate (4 µg for DOTAP-low and DC-low; 64 µg for DO-
TAP-high and DC-high) diluted in 500 µl of PBS (pH 7.4)
were added and changes in the fluorescence emmission of
the complexes at 520 nm wave length of were monitored
while stirring for another 5 minutes. To correct for the de-
crease in fluorescence by increasing the volume, the fluo-
rescence intensities obtained after addition of PBS were
subtracted from the values obtained after addition of PBS
with DNA. The resulting change in fluorescence intensi-
ties was added to the fluorescence value obtained with li-
posomes alone. To determine the effect of serum, 800 µl
of FBS was added and mixed briefly. Fluorescence values
were monitored and corrected for dilution as before. Fi-
nally 66 µl of Triton X-100 (0.2% v/v) was mixed with the
complexes to completely solubilize the vesicles. The mean
of the fluorescence intensity values obtained after addi-
tion of Triton X-100 was set as 100% and all values were
expressed as percentage of this mean.
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